Versant Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,059
| Closed | -$21K | – | 2099 |
|
|
2023
Q1 | $21K | Hold |
1,059
| – | – | 0.01% | 472 |
|
|
2022
Q4 | $14.4K | Buy |
1,059
+55
| +5% | +$766 | 0.01% | 562 |
|
|
2022
Q3 | $14K | Sell |
1,004
-55
| -5% | -$817 | 0.01% | 555 |
|
|
2022
Q2 | $15K | Sell |
1,059
-241
| -19% | -$4.18K | 0.01% | 540 |
|
|
2022
Q1 | $29K | Buy |
1,300
+312
| +32% | +$6.06K | 0.01% | 375 |
|
|
2021
Q4 | $19K | Sell |
988
-299
| -23% | -$7.98K | 0.01% | 524 |
|
|
2021
Q3 | $42K | Sell |
1,287
-66
| -5% | -$2.46K | 0.01% | 269 |
|
|
2021
Q2 | $58K | Buy |
1,353
+335
| +33% | +$13.1K | 0.02% | 212 |
|
|
2021
Q1 | $39K | Buy |
1,018
+30
| +3% | +$1.28K | 0.01% | 353 |
|
|
2020
Q4 | $43K | Hold |
988
| – | – | 0.02% | 289 |
|
|
2020
Q3 | $38K | Hold |
988
| – | – | 0.02% | 267 |
|
|
2020
Q2 | $31K | Hold |
988
| – | – | 0.01% | 307 |
|
|
2020
Q1 | $34K | Hold |
988
| – | – | 0.02% | 253 |
|
|
2019
Q4 | $48K | Hold |
988
| – | – | 0.02% | 223 |
|
|
2019
Q3 | $46K | Hold |
988
| – | – | 0.02% | 226 |
|
|
2019
Q2 | $42K | Hold |
988
| – | – | 0.02% | 249 |
|
|
2019
Q1 | $38K | Hold |
988
| – | – | 0.02% | 354 |
|
|
2018
Q4 | $28K | Sell |
988
-2,775
| -74% | -$88.2K | 0.01% | 410 |
|
|
2018
Q3 | $147K | Buy |
+3,763
| New | +$139K | 0.06% | 113 |
|
Other funds holding CSII
Versant Capital Management's CSII Position: Q2 2023 in Review
Versant Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 1,059 shares — an estimated $21K sold.
Versant Capital Management first reported a position in CSII in Q3 2018 and held it in 19 quarters. The position peaked at $147K in Q3 2018. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Versant Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Versant Capital Management sold 1,059 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $21K.
- Versant Capital Management first reported a position in Cardiovascular Systems, Inc. in Q3 2018 and held it in 19 quarters.
- Versant Capital Management's Cardiovascular Systems, Inc. position peaked at $147K in Q3 2018.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Versant Capital Management's 13F filing for Q2 2023, filed 10 Jul 2023.